Biotech JANUARY 26 FINAL DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm January 22, 2021
Biotech INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm January 22, 2021
Biotech CELSION CORPORATION ANNOUNCES $35 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES January 22, 2021
Biotech Equillium Announces Acceptance of Late-Breaking Abstract for Oral Presentation of Interim Data from EQUATE Study in acute GVHD at the 2021 TCT Meetings Digital Experience January 22, 2021
Biotech aTyr Pharma to Present Poster Highlighting Research Approach for Identifying Receptor Targets for Extracellular tRNA Synthetases January 22, 2021
Health SHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger January 21, 2021
Biotech ROSEN, TRUSTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action – FBIO January 21, 2021
Search
Biotech
January 22, 2021
January 22, 2021
January 22, 2021
January 22, 2021
January 22, 2021
January 22, 2021
January 21, 2021
January 21, 2021
January 21, 2021
January 21, 2021
